Napabucasin
Catalog No. A13474
Napabucasin是一种口服小分子药物,它可以阻止癌症干细胞(CSC)自我更新,并诱导CSC和非干细胞中的细胞死亡。
Catalog Num | A13474 |
---|---|
M. Wt | 240.21 |
Formula | C14H8O4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 83280-65-3 |
Synonyms | BBI 608, BBI608, BBI-608 |
SMILES | O=C(C1=C2OC(C(C)=O)=C1)C3=C(C2=O)C=CC=C3 |
Napabucasin是一种口服小分子药物,它可以阻止癌症干细胞(CSC)自我更新,并诱导CSC和非干细胞中的细胞死亡。
Targets
Stat3 | ||||
In vitro (25°C) | DMSO | 10 mg/mL (41.63 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+40% PEG 300+5% Tween 80+ddH2O | 1 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 41.63 mL | 208.15 mL | 416.3 mL |
0.5 mM | 8.33 mL | 41.63 mL | 83.26 mL |
1 mM | 4.16 mL | 20.82 mL | 41.63 mL |
5 mM | 0.83 mL | 4.16 mL | 8.33 mL |
*The above data is based on the productmolecular weight 240.21. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.